Skip to content

BGAgribusiness and food ingredients

Bunge Global

By

Updated

Not investment advice. Kevin may own this stock. How we value stocks

History
Price
$90.87
Intrinsic value
Intrinsic value from an AI estimate
Discount category
Close to intrinsic value (AI estimate)
Analysts
Bullish
Next earnings
Jan 29 · · estimated
Pick status
Research only

In short

Thesis
The market expects the strong processing margins of 2026 to fall back, and Viterra savings with profit from the new Destrehan line through 2027 can lift its value.
Gap
Slow. Normal earnings after the Viterra combination become clear only over several years of results with average processing margins.

Company guidance: 2026 adjusted EPS $9.25 to $9.75; capex toward the high end of $1.5 to $1.7 billion; net interest $640 to $670 million (, Q3 2026 earnings release)

Price history

About

Bunge Global SA (BG) buys, processes and sells agricultural commodities. It crushes soybeans and softseeds such as canola and sunflower into meal and oil, refines vegetable oils, makes specialty fats and ingredients, mills wheat and corn, and trades grain around the world. Its segments are Soybean Processing and Refining, Softseed Processing and Refining, Tropical Oils and Specialty Ingredients, and Grain Merchandising and Milling.

Bunge combined with Viterra in July 2025, which added a large grain origination and handling network. Net sales were $69,706 million in the first nine months of 2026. Bunge is incorporated in Switzerland, has its headquarters in Chesterfield, Missouri, and its shares trade on the New York Stock Exchange.

Thesis

The market prices Bunge close to the AI estimate, because it expects the strong processing margins of 2026 to fall back. Biofuel mandates in North America, the conflict with Iran and the war in Ukraine raised demand and prices for vegetable oils in 2026, and Bunge raised its 2026 outlook for adjusted EPS from $7.50 to $8.00 to $9.25 to $9.75. Investors do not know how much of this profit is normal. The AI estimate uses a normalized EPS below the 2026 outlook.

For the value to rise, three things must be true. Bunge must show savings from the Viterra combination in its results. The new oilseed processing line of Bunge Chevron Ag Renewables in Destrehan, Louisiana, which started production after Q3 2026, must add profit. The 2027 outlook must show that earnings stay above the 2025 level when margins are average.

The full-year 2026 results, expected in early 2027 with the first 2027 outlook, are the next test. A rise in normalized EPS would take several years of results to prove.

Valuation

AI estimate, checked by Kevin. How it is made

Show the method

The intrinsic value for Bunge Global is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of Bunge with the SEC. The method is a multiple of normalized adjusted earnings per share.

Normalized earnings are the earnings of an average year for processing and merchandising margins, not of a strong or a weak year. Adjusted earnings are after interest, so the estimate makes no debt adjustment. The Q3 2026 release of October 29, 2026 keeps the 2026 outlook for adjusted EPS at $9.25 to $9.75. The first 2026 outlook in the Q4 2025 release of February 4, 2026 was $7.50 to $8.00, and Bunge raised it in April and July 2026.

The Q4 2025 release gives adjusted EPS of $7.57 for 2025 and $9.19 for 2024. Adjusted EPS was $6.38 in the first nine months of 2026. The Q3 2026 10-Q gives 192,143,784 registered shares outstanding at October 27, 2026 and 194,049,036 diluted weighted shares for Q3 2026. It gives total debt of $16,746 million and cash of $524 million at September 30, 2026, against readily marketable inventories of $14,696 million that Bunge can sell for cash quickly.

Bunge expects net interest expense of $640 to $670 million in 2026. The normalized EPS and the multiples are assumptions. The low case assumes $7.50, the low end of the first 2026 outlook, at 10 times. It gives $75.00 per share.

The base case assumes $9.00, a little below the 2026 outlook, because biofuel demand and trade disruption made 2026 margins strong, at 11.5 times. It gives $103.50 per share. The high case assumes $11.00, with savings from the Viterra combination and the new Destrehan processing line, at 12.5 times. It gives $137.50 per share.

The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $104.88 per share. Processing margins change with crops, trade policy and biofuel rules, so normalized EPS is hard to predict. Efficient scale and cost advantage are the possible sources of a lasting edge.

Bunge has a large global network of processing plants, ports and grain elevators, and the Viterra combination of July 2025 made it larger. But its margins depend on markets that Bunge does not control, and other large merchants have similar networks. Switching costs and network effects are weak, because customers buy commodities on price.

Checkpoints

  1. Jan 29, 2027 · est.Pending
    Full-year 2026 results and 2027 outlook2026 adjusted EPS is within $9.25 to $9.75 and the first 2027 outlook is above the 2025 level of $7.57, and this passes; a 2027 outlook at or below $7.57 fails.
  2. 2027 · est.Pending
    Viterra savings and Destrehan in the resultsBunge reports savings from the Viterra combination and profit from the new Destrehan processing line through 2027, and this passes; no clear savings fail.

Every passed and failed checkpoint across all picks

Recent events

  • October 29, 2026Bunge reported Q3 2026 adjusted EPS of $2.56, up from $2.27, and kept its 2026 outlook for adjusted EPS of $9.25 to $9.75. It said that the new oilseed processing line of Bunge Chevron Ag Renewables in Destrehan, Louisiana, started production after the quarter.
  • September 17, 2026Bunge extended three revolving credit facilities: $1.1 billion to October 2027, $4.2 billion to October 2031 and $3.5 billion to October 2029.
  • August 31, 2026Bunge agreed to sell its two sugarcane mills in Brazil to COFCO International for about $383 million. It recorded an impairment loss of $66 million.
Show 6 older events
  • August 19, 2026Bunge issued $600 million of 5.000% senior notes due 2031.
  • July 29, 2026Bunge reported Q2 2026 results and raised its 2026 outlook for adjusted EPS to $9.25 to $9.75, from $9.00 to $9.50.
  • May 20, 2026Shareholders approved a dividend of $2.88 per share, paid in four quarterly payments of $0.72, up 3% from $0.70.
  • April 29, 2026Bunge reported Q1 2026 adjusted EPS of $1.83 and raised its 2026 outlook for adjusted EPS to $9.00 to $9.50, from $7.50 to $8.00.
  • March 9, 2026The board approved a new share repurchase program of up to $3.0 billion, with no end date. Bunge bought back no shares in Q3 2026.
  • February 4, 2026Bunge reported 2025 adjusted EPS of $7.57, down from $9.19 in 2024, and gave a first 2026 outlook for adjusted EPS of $7.50 to $8.00.

Latest news and filings

Last earnings
October 29, 2026 (8-K on sec.gov)
Next earnings
Expected about January 29, 2027. The company has not confirmed the date.

Every filing on SEC EDGAR (CIK 1996862)

Risks

  • Processing margins depend on crops, trade flows, biofuel rules and the wars in Ukraine and the Middle East. A change in US biofuel policy or the end of trade disruption can reduce margins fast.
  • Total debt was $16,746 million at September 30, 2026, up from $14,051 million at December 31, 2025, because Bunge borrowed to fund higher inventories. Bunge expects net interest expense of $640 to $670 million in 2026.
  • The Viterra combination is large and complex. The combination raised the number of registered shares from about 134 million to about 193 million. If Bunge does not get the planned savings, earnings per share can stay low.
  • Bunge has operations in Ukraine and other countries with war, sanctions or currency risk. In Q3 2026, it recorded charges and a tax valuation allowance because of the war in Ukraine.
  • Results of Tropical Oils and Specialty Ingredients were lower in 2026 because of trade disruption and start-up costs, and Bunge lowered its 2026 outlook for this segment in October 2026.

Key statistics

Market cap
$17B
Shares of Oct 27, 2026
Yield at current rate
3.2%
Current annual rate, at the price of Nov 20, 2026
Dividend yield
3.1%
Last 12 months, at the price of Nov 20, 2026
P/E (trailing)
15.8
Price of Nov 20, 2026
EPS (trailing)
$5.76
12 months to Sep 30, 2026
52-week range
$88.24 – $134.87
To Nov 13, 2026
Beta
0.69
Vs S&P 500, 5 years monthly, to Oct 30, 2026
Average volume
1.8M
3 months, to Nov 13, 2026

Balance sheet

Cash
$524M
Debt
$16.7B
Net debt
$16.2B
Credit line
$8.5B
undrawn

Cash against debt

Cash$524M
Debt$16.7B

debt covered by cashnet debt $16.2B

When the debt is due

12 months$7.8B
Later$8.9B

Credit ratings

  • S&P A- · stable
  • Moody's Baa1 · stable
  • Fitch BBB+ · stable

At September 30, 2026, Bunge had cash and cash equivalents of $524 million. Total debt was $16,746 million: short-term debt of $6,471 million and long-term debt of $10,275 million, of which $1,331 million is due within a year.

Dividends

Yield at the current rate
3.2% (current annual rate, at today’s price)
Dividend yield
3.1% (last 12 months, at today’s price of $90.87)
Paid per share
$2.84 in the last 12 months (4 payments)
Current annual rate
$2.88 ($0.72 × 4 a year)
Payout ratio
57% of the last fiscal year’s earnings (the year that ended December 31, 2025)
Latest ex-dividend date
August 18, 2026, $0.72 per share

Dividends per share by year

Bunge Global dividends per share by year
2016
$1.60
2017
$1.76
2018
$1.92
2019
$2.00
2020
$2.00
2021
$2.05
2022
$2.30
2023
$2.576
2024
$2.703
2025
$2.78

From 2020 to 2025, the dividend grew by about 6.8% a year. From 2016 to 2025, the dividend grew by about 6.3% a year.

Source: company filings and market data, read on November 13, 2026. The ex-dividend date is the first day a buyer no longer gets the next payment.

Questions about Bunge Global

What does Bunge Global do?

Bunge Global SA (BG) buys, processes and sells agricultural commodities. It crushes soybeans and softseeds such as canola and sunflower into meal and oil, refines vegetable oils, makes specialty fats and ingredients, mills wheat and corn, and trades grain around the world. Its market cap is $17B at the current price of $90.87.

When does Bunge Global report earnings next?

This is an estimate: Bunge Global may report on January 29, 2027. It last reported results on July 29, 2026.

Is Bunge Global stock below its intrinsic value?

Bunge Global stock is close to intrinsic value. The source of the intrinsic value is: AI estimate. This is general information, not advice.

What changed recently at Bunge Global?

The latest update is from October 29, 2026. Bunge reported Q3 2026 adjusted EPS of $2.56, up from $2.27, and kept its 2026 outlook for adjusted EPS of $9.25 to $9.75.

What are the main risks for Bunge Global?

Processing margins depend on crops, trade flows, biofuel rules and the wars in Ukraine and the Middle East. Total debt was $16,746 million at September 30, 2026, up from $14,051 million at December 31, 2025, because Bunge borrowed to fund higher inventories. The Viterra combination is large and complex.

How much debt and cash does Bunge Global have?

At September 30, 2026, Bunge Global had $16.7B of debt and $524M of cash.

Does Bunge Global pay a dividend?

Yes. The current annual dividend of Bunge Global is $2.88 per share. That is a dividend yield of 3.2% at the current price of $90.87. In the last 12 months, it paid $2.84 per share (3.1%). The latest ex-dividend date was August 18, 2026.

Valuation against peers

CompanyP/E, last 4 quartersEV/EBITDA, last yearFree cash flow yield, last year10-year average P/E
BGBunge Global15.8xn/a-5.0%10.3x
RTXRTX30.9xn/a3.1%25.3x
CNHCNH Industrial51.1xn/an/a13.7x
DDDuPont65.5xn/an/an/a
FFord Motorn/an/a27.9%8.4x
Peer median51.1xn/a15.5%n/a
  • BG trades at 15.8x earnings, 69% below the peer median of 51.1x.
  • Its free cash flow yield is -5.0%, 20.5 points below the peer median of 15.5%.
  • Against its own history, the P/E is 53% above its average of 10.3x over 5 profitable years.

The peers are the companies on this site most like BG. The multiples come from company filings and today's price. There are no analyst forecasts: they all look back. EV/EBITDA is left out for banks, insurers and real estate companies. This is general information, not advice.

Similar companies

  • AZNAstraZenecaShares: Regulation and courts, Tariffs and trade
    Intrinsic value
    Close to intrinsic value
    Gap
    Can close
  • IMBBYImperial BrandsShares: Regulation and courts, Tariffs and trade
    Intrinsic value
    Below intrinsic value
    Gap
    Slow
  • RTXRTXShares: Regulation and courts, Tariffs and trade
    Intrinsic value
    Below intrinsic value
    Gap
    Can close
  • CNHCNH IndustrialShares: Tariffs and trade, Regulation and courts
    Intrinsic value
    Deep below intrinsic value
    Gap
    Slow
  • DDDuPontShares: Regulation and courts, Tariffs and trade
    Intrinsic value
    Close to intrinsic value
    Gap
    Can close

Loading your notes…

Read it all? Star BG or pass, then go on to the next one.